MERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belén Garijo on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/03/22
WHO Backs Merck's Antiviral Pill For High-Risk Covid Patients But Finds Regeneron's Antibody Cocktail ‘Ineffective' Against OmicronForbes • 03/03/22
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell CarcinomaBusiness Wire • 02/25/22
South Africa Authorizes Merck's COVID-19 Antiviral Pill, But Government Not Buying: ReutersBenzinga • 02/17/22